drugset / Trial / NCT01039701
4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of the study is to determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil for 4 weeks in patients with mild to moderate Alzheimer's disease.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1446 | Small molecule | 30 mg | Oral |
| Subject | AZD1446 | Small molecule | 60 mg | Oral |
Indications
No indication recorded.